Indeed, the TCGA database indicates high SPINT2 mRNA levels in pancreatic ductal adenocarcinomas and the median level of SPINT2 mRNA is high in other major cancers such as non-small cell lung cancers, colon cancers, breast cancers and prostatic cancers. This evidence concerns the gene SPINT2 and prostate carcinoma.